ASX/AIM Announcement 18 September 2025
Wellnex Life Limited (ASX/AIM:WNX)
Wellnex Life secures New Zealand distributor for the Company's expansion of its innovative brands
Highlights
· Wellnex Life appoints leading New Zealand distributor Storelink to represent the Company's brands in the New Zealand market
· Following the Company's Pain Away brand relaunch in Chemist Warehouse New Zealand last year, Wellnex Life is focused on driving growth through the New Zealand market with the planned expansion of other brands
· The appointment of Storelink in New Zealand supports the Company's strategy to increase awareness of the Company and its brands in additional regional markets
Wellnex Life Limited (ASX/AIM: WNX) (Wellnex Life or Company) is pleased to announce the appointment of Storelink Sales Limited (Storelink) as its distribution partner to take the Company's innovative brands into the New Zealand market.
Wellnex Life, on the back of its late 2024 Pain Away brand relaunch in Chemist Warehouse New Zealand, has identified additional grocery and pharmacy channel opportunities in the New Zealand market for its brands. Storelink was identified as the ideal partner for the New Zealand market to help accelerate the growth of Wellnex Life brands in additional regional markets.
Wellnex Life will work closely with and support Storelink to commence presenting its brands to New Zealand retailers over the coming months, with sales planned to commence in the first half this financial year.
About Storelink
Storelink is one of New Zealand's largest full-service retail execution specialists. For over 35 years, Storelink has helped ambitious FMCG brands get seen, sold and scaled - everywhere that matters.
Tony Puppyn, General Manager of Storelink said: "Storelink is thrilled with our collaboration with Australian company Wellnex Life. We are eagerly looking forward to the opportunity to introduce Wellnex Life's exciting and innovative brands to the New Zealand market. Together, we aim to enhance the well-being of individuals across New Zealand with Wellnex Life's exceptional products."
Zack Bozinovski CEO Wellnex Life said: "We are excited to partner with a highly experienced and regarded company such as Storelink, to help distribute our innovative and exciting brands throughout the grocery and pharmacy channels in New Zealand. The Storelink team demonstrated a strong understanding of our Company brands and an even stronger alignment to our distribution objectives. The ability to now have our Australian brands available in the New Zealand market formed part of Company's strategic focus post our UK distribution partner announcement earlier this year. The Wellnex Life team look forward to closely working with Tony and his team to execute our brand strategy into the New Zealand retailers."
To stay up to date on company news and announcements, please register your details on the Wellnex Life Limited investor portal: https://wellnexlife.investorportal.com.au/register/
This ASX/AIM announcement has been authorised by the Board of Wellnex Life Limited (ASX/AIM:WNX).
For further information, please contact:
Wellnex Life Limited (ASX:WNX) Reach Markets
Zack Bozinovski T: 1300 805 795
Chief Executive Officer & Managing Director E: IR@reachmarkets.com.au
P: +61 3 8399 9419
UK Investors
Strand Hanson (Financial & Nominated Advisor)
James Harris / Richard Johnson Tel: +44 (0) 20 7409 3494
Orana Corporate LLP (Joint Broker) swykeham@oranacorp.com
Sebastian Wykeham
S.P. Angel Corporate Finance LLP (Joint Broker) Tel: +44 (0)20 3470 0470
David Hignell / Vadim Alexandre
About Wellnex Life
Wellnex Life Limited (ASX/AIM:WNX) is a consumer healthcare business with a track record for developing, licensing, and marketing registered products and brands to customers in the growing healthcare market segment. Since listing on ASX in 2021, Wellnex Life has successfully launched a host of brands and products now ranged in major retailers in the healthcare market space, pharmacies and supermarkets. Its distribution arrangements have seen Wellnex Life secure significant licensing arrangements with major pharmaceutical companies in Australia and globally that have given the Company's registered products a distribution channel with a steadily increasing global geographic footprint.
In December 2023, Wellnex Life acquired leading Australian topical pain relief brand Pain Away. Its addition to Wellnex Life's product offering both compliments and accelerates the potential growth of the company's business operations. This transformational acquisition gives added impetus to Wellnex Life's financial growth and scale and reinforces its place as a major and respected participant in the growing healthcare market, both in Australia and overseas.
To learn more, please visit: www.Wellnex Lifelife.com.au/
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
